(Q36123746)

12 August 2017

1 reference

title

Neurohormonal intervention to reduce sudden cardiac death in heart failure: what is the optimal pharmacologic strategy? (English)

1 reference

12 August 2017

Iain Squire

1

1 reference

12 August 2017

1 October 2004

1 reference

12 August 2017

Heart Failure Reviews

1 reference

12 August 2017

9

1 reference

12 August 2017

4

1 reference

12 August 2017

337-45; discussion 347-51

1 reference

https://scigraph.springernature.com/pub.10.1007/s10741-005-7301-6

12 August 2017

0 references

cites work

Incidence of sudden cardiac death associated with coronary artery occlusion in dogs with hypertension and left ventricular hypertrophy is reduced by chronic beta-adrenergic blockade

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10741-005-7301-6

A randomized trial of beta-blockade in heart failure. The Cardiac Insufficiency Bisoprolol Study (CIBIS). CIBIS Investigators and Committees

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10741-005-7301-6

Aldosterone induces acute endothelial dysfunction in vivo in humans: evidence for an aldosterone-induced vasculopathy

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10741-005-7301-6

Exploration of the precision of classifying sudden cardiac death. Implications for the interpretation of clinical trials

21 January 2018

1 reference

12 December 2020

The Effect of the Angiotensin-Converting–Enzyme Inhibitor Zofenopril on Mortality and Morbidity after Anterior Myocardial Infarction

1 reference

12 December 2020

A trial of the beta-blocker bucindolol in patients with advanced chronic heart failure

1 reference

12 December 2020

QT dispersion and sudden unexpected death in chronic heart failure

1 reference

12 December 2020

The relationships among ventricular arrhythmias, left ventricular dysfunction, and mortality in the 2 years after myocardial infarction

1 reference

12 December 2020

Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both

1 reference

12 December 2020

Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease

1 reference

12 December 2020

Chronic administration of aldosterone depresses baroreceptor reflex function in the dog

1 reference

12 December 2020

Angiotensin-converting enzyme inhibition after myocardial infarction: the Trandolapril Cardiac Evaluation Study

1 reference

12 December 2020

How often are angiotensin II and aldosterone concentrations raised during chronic ACE inhibitor treatment in cardiac failure?

1 reference

12 December 2020

Aldosterone blunts the baroreflex response in man

1 reference

12 December 2020

Arrhythmias and sudden death in heart failure

1 reference

12 December 2020

A comparative analysis of the results from 4 trials of beta-blocker therapy for heart failure: BEST, CIBIS-II, MERIT-HF, and COPERNICUS.

1 reference

12 December 2020

Aldosterone inhibition limits collagen synthesis and progressive left ventricular enlargement after anterior myocardial infarction.

1 reference

12 December 2020

Mode of death in heart failure: findings from the ATLAS trial

1 reference

12 December 2020

Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction

1 reference

12 December 2020

Effects of adding spironolactone to an angiotensin-converting enzyme inhibitor in chronic congestive heart failure secondary to coronary artery disease

1 reference

12 December 2020

Nonsustained ventricular tachycardia in severe heart failure. Independent marker of increased mortality due to sudden death. GESICA-GEMA Investigators

1 reference

12 December 2020

Trandolapril reduces the incidence of atrial fibrillation after acute myocardial infarction in patients with left ventricular dysfunction

1 reference

12 December 2020

Evolving trends in the epidemiologic factors of heart failure: rationale for preventive strategies and comprehensive disease management

1 reference

12 December 2020

Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

1 reference

12 December 2020

Effects of losartan and captopril on mortality and morbidity in high-risk patients after acute myocardial infarction: the OPTIMAAL randomised trial. Optimal Trial in Myocardial Infarction with Angiotensin II Antagonist Losartan

1 reference

12 December 2020

Effect of ramipril on morbidity and mode of death among survivors of acute myocardial infarction with clinical evidence of heart failure. A report from the AIRE Study Investigators

1 reference

12 December 2020

The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group

1 reference

12 December 2020

Metoprolol CR/XL in postmyocardial infarction patients with chronic heart failure: experiences from MERIT-HF

1 reference

12 December 2020

Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF). MERIT-HF Study Group

1 reference

12 December 2020

Theodore Cooper Lecture: Tissue angiotensin and pathobiology of vascular disease: a unifying hypothesis.

1 reference

12 December 2020

ACE inhibitors suppress ischemia-induced arrhythmias by reducing the spatial dispersion of ventricular repolarization

1 reference

12 December 2020

Exercise-induced ventricular arrhythmias in congestive heart failure and role of ACE inhibitors

1 reference

12 December 2020

A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure

1 reference

12 December 2020

The associations of levels of serum potassium and magnesium with ventricular premature complexes (the Framingham Heart Study)

1 reference

12 December 2020

Aldosterone blockade reduces vascular collagen turnover, improves heart rate variability and reduces early morning rise in heart rate in heart failure patients

1 reference

12 December 2020

Mechanism by which quinapril improves vascular function in coronary artery disease

1 reference

12 December 2020

Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators

1 reference

12 December 2020

Aldosterone in congestive heart failure

1 reference

12 December 2020

Propranolol therapy in patients with acute myocardial infarction: the Beta-Blocker Heart Attack Trial

1 reference

12 December 2020

Comparison of Spirapril, Isradipine, or Combination in Hypertensive Patients With Left Ventricular Hypertrophy Effects on LVH Regression and Arrhythmogenic Propensity

1 reference

12 December 2020

Two-year time course and significance of neurohumoral activation in the Survival and Ventricular Enlargement (SAVE) Study

1 reference

12 December 2020

Short-term heart rate variability strongly predicts sudden cardiac death in chronic heart failure patients.

1 reference

12 December 2020

Addition of spironolactone to angiotensin-converting enzyme inhibition in heart failure improves endothelial vasomotor dysfunction: role of vascular superoxide anion formation and endothelial nitric oxide synthase expression

1 reference

12 December 2020

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

1 reference

12 December 2020

Effects of long-term monotherapy with eplerenone, a novel aldosterone blocker, on progression of left ventricular dysfunction and remodeling in dogs with heart failure

1 reference

12 December 2020

Angiotensin-converting enzyme and endothelial nitric oxide synthase polymorphisms in patients with atrial fibrillation

1 reference

12 December 2020

The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial

1 reference

12 December 2020

Diverse mechanisms of unexpected cardiac arrest in advanced heart failure

1 reference

12 December 2020

Prognostic importance of the serum magnesium concentration in patients with congestive heart failure

1 reference

12 December 2020

Effect of propranolol on ventricular arrhythmia. The beta-blocker heart attack trial experience

1 reference

12 December 2020

Effects of beta-blockade on the incidence of ventricular tachyarrhythmias during acute myocardial ischemia: experimental findings and clinical implications.

1 reference

12 December 2020

Primary prevention of sudden cardiac death in heart failure: will the solution be shocking?

1 reference

12 December 2020

Significance and control of cardiac arrhythmias in patients with congestive cardiac failure

1 reference

12 December 2020

Acute coronary findings at autopsy in heart failure patients with sudden death: results from the assessment of treatment with lisinopril and survival (ATLAS) trial

1 reference

12 December 2020

Mechanism of death and prevalence of myocardial ischemic symptoms in the terminal event after acute myocardial infarction.

1 reference

12 December 2020

Clinical classification of cardiac deaths

1 reference

12 December 2020

Endothelial dysfunction and cardiovascular disease: the promise of blocking the renin-angiotensin system

1 reference

12 December 2020

Effect of angiotensin-converting enzyme therapy on QT interval dispersion

1 reference

12 December 2020

Consensus recommendations for the management of chronic heart failure

1 reference

12 December 2020

Aldosterone: cardiovascular assault.

1 reference

12 December 2020

ACE inhibition improves cardiac NE uptake and attenuates sympathetic nerve terminal abnormalities in heart failure

1 reference

12 December 2020

Pathophysiologic mechanisms of cardiac arrhythmias

1 reference

12 December 2020

Anti-arrhythmic efficacy of beta-adrenergic blockade during acute ischemia in myocardium with scar.

1 reference

12 December 2020

Metoprolol controlled release/extended release in patients with severe heart failure: analysis of the experience in the MERIT-HF study

1 reference

12 December 2020

Spironolactone increases nitric oxide bioactivity, improves endothelial vasodilator dysfunction, and suppresses vascular angiotensin I/angiotensin II conversion in patients with chronic heart failure

1 reference

12 December 2020

Effect of carvedilol on the morbidity of patients with severe chronic heart failure: results of the carvedilol prospective randomized cumulative survival (COPERNICUS) study

1 reference

12 December 2020

MERIT-HF mortality and morbidity data

1 reference

12 December 2020

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

1 reference

12 December 2020

Effect of the angiotensin II type 1 receptor blocker candesartan on endothelial function in patients with essential hypertension

1 reference

12 December 2020

Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial

1 reference

12 December 2020

Role of beta blockade in the treatment of myocardial ischemia

1 reference

12 December 2020

Survival in men with severe chronic left ventricular failure due to either coronary heart disease or idiopathic dilated cardiomyopathy

1 reference

12 December 2020

Enalapril effects on atrial remodeling and atrial fibrillation in experimental congestive heart failure

1 reference

12 December 2020

10.1007/S10741-005-7301-6

Identifiers

DOI

1 reference

12 August 2017

1 reference

PubMed ID

15886979